البيانات السريرية والمقالات والدراسات

Lip rejuvenation and plumping using an Nd:YAG 1064nm laser with a 650-microsecond pulse duration can provide significant improvement without the use of needles and with a high degree of patient satisfaction, minimal discomfort, no adverse effects and strong interest in ongoing treatments among those treated.

The efficacy of this laser on this uniquely broad range of conditions, aside from the underlying versatility of the 1064nm wavelength, is related to its ability to produce a very wide range of fluences at the 650-microsecond pulse duration, which in turn enables the clinician to treat areas with multiple passes or pulses of the laser even on tanned or darker skin tones, for maximum tissue response.

The implications to this are that laser plays an integral role in eliminating nail fungus by damaging the susceptible representations of the organism.

While melasma affects people of all skin types, it is predominant in women with darker skin (Fitzpatrick III-VI), which can add further difficulty to an already hard-to-treat, chronic disorder.

Participants had acute lumbago, which occurred within 1 to 7 days before treatment. 28 patients were exposed to laser treatment, whereas 22 were enrolled as a control group.

Laser and light-based treatments for acne have a long history of use and address the desire for interventions that can overcome the problems of poor patient compliance with topical therapies and side effects accompanying systemic medications.

This 650-microsecond laser effectively and safely treats both pediatric and adult acne patients, regardless of skin type. It penetrates deeper than any other laser/light modality, allowing energy to reach sebaceous glands where it will achieve bacterial destruction.

In the last three years we enrolled 30 patients, from 25 to 60 years old, with chronic IPP.

This study was conducted to evaluate the safety and clinical efficacy of a 650-microsecond Short Pulsed Nd:YAG 1064nm Laser for treatment of Infantile Hemangiomas.

This study was conducted to evaluate the safety and clinical efficacy of a novel short pulsed, 650 microsecond pulsed 1064nm NdYag laser for the treatment of lower extremity telangiectasias.

The purpose of this study was to evaluate the treatment of onychomycosis using a novel 0.65-millisecond (ms) pulsed 1064-nm laser.

The 1064nm laser modality has been proven to be effective in clearing onychomycosis, as long as the pulse duration is in the submillisecond range and the fluence is at least 40-50 joules per square centimeter.